Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Care 30:e110 2007
DOI: 10.2337/dc07-1288
© 2007 by the American Diabetes Association
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyko, E. J.
Right arrow Articles by Shaw, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyko, E. J.
Right arrow Articles by Shaw, J. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Online Letters: Comments and Responses

Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of Women: the Women’s Health Initiative Observational Study

Response to Song et al.

Edward J. Boyko, MD, MPH1,2, Dianna Magliano, PHD2 and Jonathan E. Shaw, MD2

1 Department of Medicine, University of Washington School of Medicine, Seattle, Washington
2 International Diabetes Institute, Caulfield, Victoria, Australia

Address correspondence to Edward J. Boyko, MD, MPH, Seattle ERIC, 1100 Olive Way, Suite 1400, Seattle, WA 98101. E-mail: eboyko{at}u.washington.edu

We read with interest the article (1) on the risk of incident diabetes in the Women’s Health Initiative Observational Study (WHI-OS) in relation to homeostasis model assessment (HOMA) of insulin resistance (HOMA-IR) and β-cell function (HOMA-B). In this letter, we raise a number of issues that we believe require further clarification.

The aim of Song et al.’s study was "to prospectively examine the relations of HOMA ... with diabetes risk" (1). Why, then, are 766 women with a fasting glucose at baseline ≥126 mg/dl included in the analysis? Although these women were excluded from other analyses, it is unclear why they were included in the first place, given the stated aim to prospectively estimate risk.

We disagree with the conclusion that the effects of high HOMA-IR and low HOMA-B (see Table 4 of Ref. 1) on diabetes risk are additive. We believe that the combined effects (odds ratio 36.9) exceed what would be expected from a combination of the individual effects (HOMA-IR 9.97 and HOMA-B 1.72) under not only an additive (9.97 + 1.72 – 1 = 10.69) but also a multiplicative (1.72 x 9.97 = 17.15) model. Our reanalysis of the crude data presented in Table 4 for the multiplicative interaction of HOMA-IR by HOMA-B using logistic regression resulted in a significant P value of 0.009 for the interaction term coefficient (β = 0.726) by the likelihood ratio test, indicating that the null hypothesis of no interaction is rejected. This result suggests the presence of biologic synergy between high insulin resistance and low insulin secretion in the development of type 2 diabetes, but unfortunately this is not discussed in the article. We acknowledge that our reanalysis is limited, as we could not exclude women with glucose ≥126 mg/dl at baseline and lacked information on matching factors and covariates. Further analysis of interaction by the authors would be welcome.

The authors propose that low statistical power due to exclusion of 762 women with fasting glucose ≥126 mg/dl at baseline explains widening of CIs. In one comparison among Asian/Pacific Islander women, the width of the CIs for the odds ratio for fasting glucose and diabetes risk ranges from 0.19 to 111,426. We do not believe that low power alone could explain this extreme widening and would be concerned about other known causes of variance inflation, such as multicollinearity.

We also find the models presented in Table 2 to be ambiguous regarding which covariates were included. We cannot determine whether multivariable models 1 and 2 in Table 2 include fasting glucose, insulin, HOMA-IR, and HOMA-B in the same model, or whether multivariable models 1 and 2 each display four separate models (one each for glucose, insulin, or HOMA-IR or -B). We note that if the former is true, then the authors would have included two variables in the same regression model that they report are correlated to r = 0.99 (HOMA-IR and fasting insulin), which would raise concerns about multicollinearity. We look forward to further publications on diabetes and related conditions from this large cohort.

References

  1. Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Nathan L, Rifai N, Liu S: Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women’s Health Initiative Observational Study. Diabetes Care 30: 1747–1752, 2007[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
Y. Song and S. Liu
Insulin Sensitivity and Insulin Secretion Determined by Homeostasis Model Assessment and Risk of Diabetes in a Multiethnic Cohort of Women: the Women's Health Initiative Observational Study: Response to Boyko et al.
Diabetes Care, November 1, 2007; 30(11): e111 - e111.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyko, E. J.
Right arrow Articles by Shaw, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyko, E. J.
Right arrow Articles by Shaw, J. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum